United States · Series B startup

Who invested in Omniome

One round we have observed, with the 7 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$60Mraised across 1 round since 2018, from 1 source

Latest round
Series B, $60MJul 2018
Investors
7
See who backed them

The rounds

  1. Jul 2018
    Series B$60M

    Reported by FinSMEs

Founders and team

From the SEC filings it signed: 5 on the team.

  • Arnold S. OliphantExecutive Officeri
  • Catherine S. LeeExecutive Officeri
  • David S. MullarkeyExecutive Officer, Directori
  • Kelly S. PerezExecutive Officeri
  • Ken S. SongExecutive Officer, Directori

On the board, as filediDan S. ZabrowskiDavid S. CruikshankKim S. KamdarMichael S. Yi

Everyone who backed them

ArchHedge fund1round
Decheng CapitalVC firm1round
Biomatics CapitalVC firm1round
Nan Fung Life SciencesGrowth equity1round
Domainno record of our own yet1round
Hillhouse Capital Group/ Lam Researchno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Omniome as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

ARCH Venture PartnersVC firmPer its own site
Lam CapitalVC firmPer its own site

Quick answers about Omniome

Who invested in Omniome?

Omniome's investors include Arch, Decheng Capital, Altitude Life Science Ventures, Biomatics Capital and Nan Fung Life Sciences, and 2 more on record.

How much has Omniome raised?

Omniome has raised $60M across 1 round since 2018.

When did Omniome last raise?

Omniome's most recent round was a Series B of $60M in Jul 2018.

What was Omniome's biggest round?

Its most recent round, $60M in Jul 2018, is also its largest on record.

Who backed Omniome first?

Omniome's first round on record, in Jul 2018, was backed by Arch, Decheng Capital and Altitude Life Science Ventures and 4 others.

What stage is Omniome at?

Omniome's latest named round is a Series B, in Jul 2018.

Where is Omniome based?

Omniome is based in the United States.

Companies like Omniome

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.